SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (607)10/29/2021 8:03:11 PM
From: JamesK1 Recommendation

Recommended By
scaram(o)uche

  Read Replies (1) of 684
 
They report quarterly results next week. This is what they said last quarter...

  • Expect to deliver three key clinical milestones in second half of 2021:
  • Dose first patients in global Phase 1/2 trials for PBFT02 and PBKR03 in 3Q21
  • Report initial safety and 30-day biomarker data from Imagine-1 global Phase 1/2 trial of PBGM01 for the treatment of infantile GM1 in 4Q21


    • Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

    HomeMailHotSubjectMarksPeopleMarksKeepersSettings
    Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
    © 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News